[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL2328594T3 - Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS - Google Patents

Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS

Info

Publication number
PL2328594T3
PL2328594T3 PL09786159.5T PL09786159T PL2328594T3 PL 2328594 T3 PL2328594 T3 PL 2328594T3 PL 09786159 T PL09786159 T PL 09786159T PL 2328594 T3 PL2328594 T3 PL 2328594T3
Authority
PL
Poland
Prior art keywords
stem cells
adipose tissue
cells derived
stromal stem
derived form
Prior art date
Application number
PL09786159.5T
Other languages
English (en)
Inventor
Mario Delgado
Elena Gonzalez-Rey
Dirk Büscher
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of PL2328594T3 publication Critical patent/PL2328594T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/02Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL09786159.5T 2008-08-04 2009-08-03 Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS PL2328594T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0814249.9A GB0814249D0 (en) 2008-08-04 2008-08-04 Uses of mesenchymal stem cells

Publications (1)

Publication Number Publication Date
PL2328594T3 true PL2328594T3 (pl) 2016-09-30

Family

ID=39767494

Family Applications (1)

Application Number Title Priority Date Filing Date
PL09786159.5T PL2328594T3 (pl) 2008-08-04 2009-08-03 Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS

Country Status (12)

Country Link
US (2) US20120027730A1 (pl)
EP (2) EP2328594B1 (pl)
JP (3) JP6178970B2 (pl)
KR (2) KR101974842B1 (pl)
AU (1) AU2009278853B2 (pl)
CA (2) CA2732908C (pl)
DK (1) DK2328594T3 (pl)
ES (1) ES2575165T3 (pl)
GB (1) GB0814249D0 (pl)
HU (1) HUE029213T2 (pl)
PL (1) PL2328594T3 (pl)
WO (1) WO2010015929A2 (pl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060045872A1 (en) 2004-08-25 2006-03-02 Universidad Autonoma De Madrid Ciudad Universitaria de Cantoblanco Use of adipose tissue-derived stromal stem cells in treating fistula
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells
EP3150703A1 (en) 2009-07-09 2017-04-05 TiGenix, S.A.U. Cells for use in a method for treating inflammatory and/or immune disorders
KR101900664B1 (ko) * 2011-01-12 2018-09-21 타이제닉스, 에스.에이.유. 자가면역 및 염증성 질환에서 림프내 투여를 위한 지방-유래 중간엽 줄기 세포
CN103547275B (zh) 2011-04-06 2016-12-28 桑比欧公司 用于调节外周免疫功能的方法和组合物
US20140134140A1 (en) * 2012-11-09 2014-05-15 Case Western Reserve University Mesenchymal stem cell compositions for the treatment of microbial infections
EP3066193B1 (en) * 2013-11-04 2024-07-10 Isopogen Pty Ltd Cell culture method
US20170166869A1 (en) * 2014-02-04 2017-06-15 Jose Javier Lopez GONZALEZ Biologically optimized adult mesenchymal stem cells
JP6628253B2 (ja) * 2014-02-11 2020-01-08 ブレインストーム セル セラペウティクス リミテッド 細胞の適性を判定する方法
JP6722599B2 (ja) * 2014-06-30 2020-07-15 ティジェニクス エス.エー.ユー. 全身性炎症反応症候群の治療のための間葉系間質細胞
GB201604304D0 (en) 2016-03-14 2016-04-27 Tigenix S A U Adipose tissue-derived stromal stem cells for use in treating refractory complex perianal fistulas in crohn's disease
CN106042962A (zh) * 2016-06-18 2016-10-26 合肥松雷信息科技有限公司 一种充电桩底座
US20190255116A1 (en) * 2016-10-18 2019-08-22 Osaka University Kit for preparing disease-treating agent, disease-treating agent and method for preparing disease-treating agent
CN110520138A (zh) 2017-02-28 2019-11-29 洛林大学 从华顿氏胶获得的用于治疗脓毒症的间充质干细胞
US20220010281A1 (en) 2018-10-29 2022-01-13 Ottawa Hospital Research Institute Genetically-engineered mesenchymal stem cells overexpressing aoah and uses thereof
CN112646773B (zh) * 2021-01-21 2021-12-21 华夏源(上海)生物科技有限公司 一种高效率的人间充质干细胞诱导分化成脂的方法
US20240238348A1 (en) 2021-05-13 2024-07-18 Stemmed Inc. Composition and use thereof
JP2024527558A (ja) * 2021-07-06 2024-07-25 コングク ユニバーシティ インダストリアル コーオペレーション コーポレーション 間葉系幹細胞、これから分離された細胞外小胞、及びこれらの用途
WO2024110591A1 (en) 2022-11-23 2024-05-30 DRK-Blutspendedienst Baden-Württemberg-Hessen gGmbH Biomarkers predictive of immunomodulatory mesenchymal stromal cells
CN117224577B (zh) * 2023-09-21 2024-02-27 浙江大学 干细胞凋亡小体在制备治疗复发性流产的药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6546105B1 (en) 1998-10-30 2003-04-08 Matsushita Electric Industrial Co., Ltd. Sound image localization device and sound image localization method
CA2784829C (en) * 2003-04-01 2015-10-06 United States Of America Department Of Veteran's Affairs Stem-cell, precursor cell, or target cell-based treatment of multi-organ failure and renal dysfunction
EP1727892B1 (en) * 2004-03-22 2012-05-02 Osiris Therapeutics, Inc. Mesenchymal stem cells and uses therefor
US20080095749A1 (en) * 2004-03-22 2008-04-24 Sudeepta Aggarwal Mesenchymal stem cells and uses therefor
ES2313805B1 (es) * 2004-10-04 2009-12-23 Cellerix, S.L. Identificacion y aislamiento de celulas multipotentes de tejido mesenquimal no osteocondral.
WO2007039150A2 (en) * 2005-09-23 2007-04-12 Cellerix, S.L. Cell populations having immunoregulatory activity, method for isolation and uses
WO2008036374A2 (en) * 2006-09-21 2008-03-27 Medistem Laboratories, Inc. Allogeneic stem cell transplants in non-conditioned recipients
GB0814249D0 (en) * 2008-08-04 2008-09-10 Cellerix Sa Uses of mesenchymal stem cells

Also Published As

Publication number Publication date
GB0814249D0 (en) 2008-09-10
US20220088084A1 (en) 2022-03-24
KR20110127111A (ko) 2011-11-24
CA2732908A1 (en) 2010-02-11
HUE029213T2 (en) 2017-02-28
AU2009278853B2 (en) 2015-09-17
AU2009278853A1 (en) 2010-02-11
KR101764643B1 (ko) 2017-09-05
JP6285901B2 (ja) 2018-02-28
DK2328594T3 (en) 2016-04-04
KR20170098933A (ko) 2017-08-30
US20120027730A1 (en) 2012-02-02
JP6178970B2 (ja) 2017-08-16
EP2328594A2 (en) 2011-06-08
KR101974842B1 (ko) 2019-05-03
ES2575165T3 (es) 2016-06-24
EP2328594B1 (en) 2016-03-16
CA3034718A1 (en) 2010-02-11
WO2010015929A2 (en) 2010-02-11
CA2732908C (en) 2019-06-04
EP3095449A1 (en) 2016-11-23
JP6755850B2 (ja) 2020-09-16
JP2011529957A (ja) 2011-12-15
WO2010015929A3 (en) 2010-04-29
JP2018080174A (ja) 2018-05-24
JP2016040256A (ja) 2016-03-24

Similar Documents

Publication Publication Date Title
PL2328594T3 (pl) Komórki macierzyste zrębu uzyskane z tkanki tłuszczowej do zastosowania w leczeniu SIRS
HUS1800039I1 (hu) Zsírszövet-eredetû stromális õssejtek alkalmazása sipoly kezelésében
HK1196034A1 (zh) 細胞及組織的冷凍保存用組合物
EP2183358A4 (en) PROCESS FOR THE PREPARATION OF DERMAL PAPER TISSUE EMPLOYING MESENCHYMAL STEM CELLS
IL204566A (en) Adherent cells from fat or placenta tissue for use in healing
HK1216883A1 (zh) 幹細胞培養
EP2315829A4 (en) INDUCED PLURIPOTENT STEM CELLS
EP2326710A4 (en) THERAPEUTIC METHODS USING SUSPENSIONS OF CELLS FROM ADIPOSE TISSUES COMPRISING ADIPOCYTES
EP2294183A4 (en) MESENCHYMAL STEM CELLS, COMPOSITIONS AND METHODS FOR TREATMENT OF CARDIAC TISSUE LESIONS
SG10201802522SA (en) Treatment of pluripotent cells
IL213260A0 (en) Methods of deriving differentiated cells from stem cells
EP2162141A4 (en) COMPOSITION FOR THE TREATMENT OF ISCHEMIC ILLNESSURE OF EXTREMITIES WITH FAT TISSUE STEM CELLS
IL207036A0 (en) Stem cell aggregates and methods for making and using
HK1169993A1 (en) Hsl inhibitors useful in the treatment of diabetes hsl
EP2212418A4 (en) METHOD FOR THE CO-CULTIVATION OF CELLS FROM CORD BLOOD AND MENSTRUELLEN STEM CELLS
EP2294182A4 (en) CULTS OF MULTIPOTENT STEM CELLS
EP2170394A4 (en) REGULATORY T CELLS IN ADIPOSIVE TISSUE
EP2305223A4 (en) AGENT FOR THE ACTIVATION OF STEM CELLS
ZA201206853B (en) Composition for use in water treatment
GB2473504B (en) Method for determining the suitability of compounds for use in treating bipolar disorder